Article
Stiripentol efficacy and safety in Dravet syndrome: a 12-year observational study.
Developmental medicine and child neurology - 1 Jun 2018
Myers Kenneth A, Lightfoot Paul, Patil Shekhar G, Cross J Helen, Scheffer Ingrid E
Abstract excerpt
AIM: To assess long-term safety and efficacy of stiripentol as an antiepileptic medication for people with Dravet syndrome. METHOD: A prospective, observational open-label study (2003-2015) of the efficacy and long-term safety of stiripentol in patients with Dravet syndrome and ongoing seizures. Frequency of generalized tonic-clonic seizures, focal seizures, status epilepticus, and adverse events were recorded....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
